Johnson & Johnson (JNJ) posts promising Phase 2b trial results for its chemotherapy releasing system TAR-200 in bladder ...

Summit Therapeutics' shares dropped 36% after ivonescimab data showed no significant survival benefit. Click to read if SMMT ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Summit and Akeso report Phase 3 success as ivonescimab shows PFS gains in NSCLC trial, with new studies and collaborations ...

Sarah Ferguson, Princess Beatrice and Princess Eugenie undertook a poignant visit on Wednesday as the trio visited the Teenage Cancer Trust at the University College Hospital in London.

CS Duale warns the public against falling prey to individuals who purport to offer registration guidance for a fee.

Having gleaned all its revenue to date from its US-approved prostate cancer imaging agent Illucix, Telix Pharmaceuticals (ASX ...

Hedge funds are rapidly reducing their exposure to global information technology stocks, with the latest sell-off marking the ...

A doctor insists that we should be paying attention to health symptoms no matter what age. It comes after she diagnosed her ...

A doctor insists that we should be paying attention to health symptoms no matter what age. It comes after she diagnosed her ...